Asia Pacific Leukapheresis Market Developments and Forecast by 2028

The leukapheresis market in Asia Pacific is expected to grow from US$ 14.69 million in 2021 to US$ 27.91 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. The COVID-19 pandemic has put a major strain on the health systems of many countries around the world. The cases of COVID-19 in India, the pandemic caused by SARS-CoV-2, has reached to 10,582,647 and total deaths above 152,000 on January 19, 2021. There is currently no proven specific therapy, and multiple novel and repurposed molecules are being used on an experimental basis. The lack of effective therapeutic options has been a major hurdle in our pandemic mitigation measures. There are a few contender medicines including the malaria drug hydroxychloroquine, an antiviral Remdesivir, and Ivermectin, a drug used for worms and other parasites, but the results are not hugely encouraging and at times conflicting. In this backdrop, plasma therapy is being seen with interest as a cure for COVID-19 patients in India. Further, Medical equipment that carries out the apheresis procedure was installed at the GMCH at nearby Thrissur last month and the technique was used for the first time in Kerala to administer plasma to a 51-year old man. The apheresis procedure was carried out by GMC's technologists working with the departments of medicine, transfusion medicine and anesthesia.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific leukapheresis market. The Asia Pacific leukapheresis market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Leukapheresis Market Segmentation

Asia Pacific Leukapheresis Market – By Product Type

• Leukapheresis Disposables
• Leukapheresis Devices

Asia Pacific Leukapheresis Market – By Application

• Research Applications
• Therapeutic Applications

Asia Pacific Leukapheresis Market – By Product Type

• Blood Component Providers and Blood Centers
• Hospitals and Transfusion Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes

Asia Pacific Leukapheresis Market – By Country

• China
• Japan
• India
• South Korea
• Australia
• Rest of APAC
• Canada  
• Mexico     

Asia Pacific Leukapheresis Market – Companies Mentioned

• Asahi Kasei Corporation                                 
• Fresenius SE & Co. KGaA                                
• Haemonetics Corporation                              
• Terumo Corporation                                        
• STEMCELL Technologies Inc.                          
• HemaCare  
• Macopharma
• AllCells
• STEMEXPRESS  
• BioIVT                     

Asia Pacific Leukapheresis Report Scope